Top Pharmaceuticals companies in Norway by Price to Earnings Ratio (P/E)
Norway
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1,383.33 |
Jan. 14, 2025 | USD 4.95 | -0.09% |
|
Norway |
|
| 2 |
118.10 |
Jan. 14, 2025 | USD 2.17 | -0.37% |
|
Norway |
|
| 3 |
32.26 |
Jan. 14, 2025 | USD 1.20 | -0.29% |
|
Norway |
|
| 4 |
-0.34 |
Jan. 14, 2025 | USD 0.19 | 2.37% |
|
Norway |
|
| 5 |
-1.61 |
Jan. 14, 2025 | USD 0.77 | -0.80% |
|
Norway |
|
| 6 |
-2.04 |
Jan. 14, 2025 | USD 0.11 | -3.45% |
|
Norway |
|
| 7 |
-2.14 |
Jan. 14, 2025 | USD 0.23 | 0.44% |
|
Norway |
|
| 8 |
-6.21 |
Jan. 14, 2025 | USD 1.36 | 33.77% |
|
Norway |
|
| 9 |
-6.59 |
Jan. 14, 2025 | USD 0.17 | -2.50% |
|
Norway |
|
| 10 |
-23.62 |
Jan. 14, 2025 | USD 0.22 | 4.62% |
|
Norway |
|
| 11 |
-51.04 |
Jan. 14, 2025 | USD 3.46 | 4.14% |
|
Norway |
Frequently Asked Questions
-
Which Pharmaceuticals company in Norway has the highest Price to Earnings Ratio (P/E) ?
The Pharmaceuticals company in Norway with the highest Price to Earnings Ratio (P/E) is Photocure ASA (Oslo Stock Exchange: PHO.OL) at 1,383.33.
-
Which Pharmaceuticals company in Norway has the lowest Price to Earnings Ratio (P/E) ?
The Pharmaceuticals company in Norway with the lowest Price to Earnings Ratio (P/E) is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at -51.04.
-
What are the top 10 Pharmaceuticals companies in Norway by Price to Earnings Ratio (P/E) ?
The top 10 Pharmaceuticals companies in Norway by Price to Earnings Ratio (P/E) are Photocure ASA, Navamedic ASA, ArcticZymes Technologies ASA, Ultimovacs ASA, BerGenBio ASA, PCI Biotech Holding ASA, Nykode Therapeutics AS, Lifecare AS, Hofseth BioCare ASA and Thor Medical ASA.
-
What are the bottom 10 Pharmaceuticals companies in Norway by Price to Earnings Ratio (P/E) ?
The bottom 10 Pharmaceuticals companies in Norway by Price to Earnings Ratio (P/E) are Gentian Diagnostics ASA, Thor Medical ASA, Hofseth BioCare ASA, Lifecare AS, Nykode Therapeutics AS, PCI Biotech Holding ASA, BerGenBio ASA, Ultimovacs ASA, ArcticZymes Technologies ASA and Navamedic ASA.